NCT05953506View on ClinicalTrials.gov

Phase 1a Study in Healthy Participants

PHASE1UnknownINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

December 24, 2023

Study Completion Date

December 24, 2023

Conditions
Healthy
Interventions
DRUG

HS-10506

HS-10506 will be administered orally once on Day 1.

DRUG

HS-10506 Placebo

Matching placebo will be administered orally once on Day 1.

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY